Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Calbiochem™ PCSK9 Inhibitor, EGF-A

Catalog No. 5087610001 Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-876-10001 1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-876-10001 Supplier MilliporeSigma™ Supplier No. 5087610001
Only null left
Add to Cart
Add to Cart

A 42-mer synthetic peptide (GTNECLDNNGGCSHVCNDLKIGYECLCPDGFQLVAQRRCEDI-NH2) that contains a calcium binding site of EGF-A

A 42-mer synthetic peptide (GTNECLDNNGGCSHVCNDLKIGYECLCPDGFQLVAQRRCEDI-NH2) that contains a calcium binding site of EGF-A. Binds to the proprotein convertase subtilisin/kexin type 9 (PCSK9) in a pH and calcium-dependent manner (Kd = 300nM at pH 5.2 and 1.0μM at pH7.4 and at 2mm calcium) and blocks its interaction with LDL receptors (IC50 = 3.4μM) and VLDL receptors (IC50 = 4.7μM). Acts as a poor inhibitor of PCSK9 - Apo-ER2 interaction even at high concentrations (∽200μM). Blocks the degradation of mature LDL receptors in HepG2 cells in a dose-dependent manner (∽1.5 to 15μM).

Please note that the molecular weight for this compound is batch-specific due to variable water content.
TRUSTED_SUSTAINABILITY

Specifications

Color White
Description 95% by HPLC
Target Proteins PCSK9
Molecular Formula C188H292N58O65S6
Solubility H2O
Content And Storage Hygroscopic, Protect from light
Form Powder
Quantity 1 mg
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.